VRTX
Vertex Pharmaceuticals Incorporated · Healthcare
SVP and Chief Accounting Officer Paul M Silva sold $910K of Vertex Pharmaceuticals Incorporated
Sold$909,828
$211.83Price
4,295Shares
−20%Stake
What VRTX did after the filing
- The stock from Fri, Feb 19 close, $207.02
- +4.0%
- S&P 500, same days
- +4.5%
Measured over 30 trading days, to the Apr 5 close.
Traded Thu, Feb 18. Filed Fri, Feb 19, 11:21 AM ET, during the session. Returns use the Feb 19 close and the Apr 5 close. Not investment advice.